Global Paclitaxel-eluting Stent Market Insights and Forecast to 2028

Report ID: 1538399 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Paclitaxel-eluting Stent Product Introduction
    1.2 Market by Type
        1.2.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Metal Stent
        1.2.3 Polymer Stent
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Coronary Heart Disease
        1.3.3 Clinical
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Paclitaxel-eluting Stent Sales Estimates and Forecasts 2017-2028
    2.2 Global Paclitaxel-eluting Stent Revenue Estimates and Forecasts 2017-2028
    2.3 Global Paclitaxel-eluting Stent Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Paclitaxel-eluting Stent Sales by Region
        2.4.1 Global Paclitaxel-eluting Stent Sales by Region (2017-2022)
        2.4.2 Global Sales Paclitaxel-eluting Stent by Region (2023-2028)
    2.5 Global Paclitaxel-eluting Stent Revenue by Region
        2.5.1 Global Paclitaxel-eluting Stent Revenue by Region (2017-2022)
        2.5.2 Global Paclitaxel-eluting Stent Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Paclitaxel-eluting Stent Sales by Manufacturers
        3.1.1 Global Top Paclitaxel-eluting Stent Manufacturers by Sales (2017-2022)
        3.1.2 Global Paclitaxel-eluting Stent Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Paclitaxel-eluting Stent in 2021
    3.2 Global Paclitaxel-eluting Stent Revenue by Manufacturers
        3.2.1 Global Paclitaxel-eluting Stent Revenue by Manufacturers (2017-2022)
        3.2.2 Global Paclitaxel-eluting Stent Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel-eluting Stent Revenue in 2021
    3.3 Global Paclitaxel-eluting Stent Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Paclitaxel-eluting Stent Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Paclitaxel-eluting Stent Sales by Type
        4.1.1 Global Paclitaxel-eluting Stent Historical Sales by Type (2017-2022)
        4.1.2 Global Paclitaxel-eluting Stent Forecasted Sales by Type (2023-2028)
        4.1.3 Global Paclitaxel-eluting Stent Sales Market Share by Type (2017-2028)
    4.2 Global Paclitaxel-eluting Stent Revenue by Type
        4.2.1 Global Paclitaxel-eluting Stent Historical Revenue by Type (2017-2022)
        4.2.2 Global Paclitaxel-eluting Stent Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Paclitaxel-eluting Stent Revenue Market Share by Type (2017-2028)
    4.3 Global Paclitaxel-eluting Stent Price by Type
        4.3.1 Global Paclitaxel-eluting Stent Price by Type (2017-2022)
        4.3.2 Global Paclitaxel-eluting Stent Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Paclitaxel-eluting Stent Sales by Application
        5.1.1 Global Paclitaxel-eluting Stent Historical Sales by Application (2017-2022)
        5.1.2 Global Paclitaxel-eluting Stent Forecasted Sales by Application (2023-2028)
        5.1.3 Global Paclitaxel-eluting Stent Sales Market Share by Application (2017-2028)
    5.2 Global Paclitaxel-eluting Stent Revenue by Application
        5.2.1 Global Paclitaxel-eluting Stent Historical Revenue by Application (2017-2022)
        5.2.2 Global Paclitaxel-eluting Stent Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Paclitaxel-eluting Stent Revenue Market Share by Application (2017-2028)
    5.3 Global Paclitaxel-eluting Stent Price by Application
        5.3.1 Global Paclitaxel-eluting Stent Price by Application (2017-2022)
        5.3.2 Global Paclitaxel-eluting Stent Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Paclitaxel-eluting Stent Market Size by Type
        6.1.1 North America Paclitaxel-eluting Stent Sales by Type (2017-2028)
        6.1.2 North America Paclitaxel-eluting Stent Revenue by Type (2017-2028)
    6.2 North America Paclitaxel-eluting Stent Market Size by Application
        6.2.1 North America Paclitaxel-eluting Stent Sales by Application (2017-2028)
        6.2.2 North America Paclitaxel-eluting Stent Revenue by Application (2017-2028)
    6.3 North America Paclitaxel-eluting Stent Market Size by Country
        6.3.1 North America Paclitaxel-eluting Stent Sales by Country (2017-2028)
        6.3.2 North America Paclitaxel-eluting Stent Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Paclitaxel-eluting Stent Market Size by Type
        7.1.1 Europe Paclitaxel-eluting Stent Sales by Type (2017-2028)
        7.1.2 Europe Paclitaxel-eluting Stent Revenue by Type (2017-2028)
    7.2 Europe Paclitaxel-eluting Stent Market Size by Application
        7.2.1 Europe Paclitaxel-eluting Stent Sales by Application (2017-2028)
        7.2.2 Europe Paclitaxel-eluting Stent Revenue by Application (2017-2028)
    7.3 Europe Paclitaxel-eluting Stent Market Size by Country
        7.3.1 Europe Paclitaxel-eluting Stent Sales by Country (2017-2028)
        7.3.2 Europe Paclitaxel-eluting Stent Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Paclitaxel-eluting Stent Market Size by Type
        8.1.1 Asia Pacific Paclitaxel-eluting Stent Sales by Type (2017-2028)
        8.1.2 Asia Pacific Paclitaxel-eluting Stent Revenue by Type (2017-2028)
    8.2 Asia Pacific Paclitaxel-eluting Stent Market Size by Application
        8.2.1 Asia Pacific Paclitaxel-eluting Stent Sales by Application (2017-2028)
        8.2.2 Asia Pacific Paclitaxel-eluting Stent Revenue by Application (2017-2028)
    8.3 Asia Pacific Paclitaxel-eluting Stent Market Size by Region
        8.3.1 Asia Pacific Paclitaxel-eluting Stent Sales by Region (2017-2028)
        8.3.2 Asia Pacific Paclitaxel-eluting Stent Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Paclitaxel-eluting Stent Market Size by Type
        9.1.1 Latin America Paclitaxel-eluting Stent Sales by Type (2017-2028)
        9.1.2 Latin America Paclitaxel-eluting Stent Revenue by Type (2017-2028)
    9.2 Latin America Paclitaxel-eluting Stent Market Size by Application
        9.2.1 Latin America Paclitaxel-eluting Stent Sales by Application (2017-2028)
        9.2.2 Latin America Paclitaxel-eluting Stent Revenue by Application (2017-2028)
    9.3 Latin America Paclitaxel-eluting Stent Market Size by Country
        9.3.1 Latin America Paclitaxel-eluting Stent Sales by Country (2017-2028)
        9.3.2 Latin America Paclitaxel-eluting Stent Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Paclitaxel-eluting Stent Market Size by Type
        10.1.1 Middle East and Africa Paclitaxel-eluting Stent Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Paclitaxel-eluting Stent Revenue by Type (2017-2028)
    10.2 Middle East and Africa Paclitaxel-eluting Stent Market Size by Application
        10.2.1 Middle East and Africa Paclitaxel-eluting Stent Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Paclitaxel-eluting Stent Revenue by Application (2017-2028)
    10.3 Middle East and Africa Paclitaxel-eluting Stent Market Size by Country
        10.3.1 Middle East and Africa Paclitaxel-eluting Stent Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Paclitaxel-eluting Stent Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Blue Medical
        11.1.1 Blue Medical Corporation Information
        11.1.2 Blue Medical Overview
        11.1.3 Blue Medical Paclitaxel-eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Blue Medical Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Blue Medical Recent Developments
    11.2 Boston Scientific
        11.2.1 Boston Scientific Corporation Information
        11.2.2 Boston Scientific Overview
        11.2.3 Boston Scientific Paclitaxel-eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Boston Scientific Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Boston Scientific Recent Developments
    11.3 DISA Vascular
        11.3.1 DISA Vascular Corporation Information
        11.3.2 DISA Vascular Overview
        11.3.3 DISA Vascular Paclitaxel-eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 DISA Vascular Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 DISA Vascular Recent Developments
    11.4 Essen
        11.4.1 Essen Corporation Information
        11.4.2 Essen Overview
        11.4.3 Essen Paclitaxel-eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Essen Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Essen Recent Developments
    11.5 Medtronic Vascular
        11.5.1 Medtronic Vascular Corporation Information
        11.5.2 Medtronic Vascular Overview
        11.5.3 Medtronic Vascular Paclitaxel-eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Medtronic Vascular Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Medtronic Vascular Recent Developments
    11.6 MicroPort Medical
        11.6.1 MicroPort Medical Corporation Information
        11.6.2 MicroPort Medical Overview
        11.6.3 MicroPort Medical Paclitaxel-eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 MicroPort Medical Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 MicroPort Medical Recent Developments
    11.7 Terumo Medical
        11.7.1 Terumo Medical Corporation Information
        11.7.2 Terumo Medical Overview
        11.7.3 Terumo Medical Paclitaxel-eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Terumo Medical Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Terumo Medical Recent Developments
    11.8 Orbusneich
        11.8.1 Orbusneich Corporation Information
        11.8.2 Orbusneich Overview
        11.8.3 Orbusneich Paclitaxel-eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Orbusneich Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Orbusneich Recent Developments
    11.9 Cook Medical
        11.9.1 Cook Medical Corporation Information
        11.9.2 Cook Medical Overview
        11.9.3 Cook Medical Paclitaxel-eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Cook Medical Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Cook Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Paclitaxel-eluting Stent Industry Chain Analysis
    12.2 Paclitaxel-eluting Stent Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Paclitaxel-eluting Stent Production Mode & Process
    12.4 Paclitaxel-eluting Stent Sales and Marketing
        12.4.1 Paclitaxel-eluting Stent Sales Channels
        12.4.2 Paclitaxel-eluting Stent Distributors
    12.5 Paclitaxel-eluting Stent Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Paclitaxel-eluting Stent Industry Trends
    13.2 Paclitaxel-eluting Stent Market Drivers
    13.3 Paclitaxel-eluting Stent Market Challenges
    13.4 Paclitaxel-eluting Stent Market Restraints
14 Key Findings in The Global Paclitaxel-eluting Stent Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Paclitaxel-eluting Stent Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Metal Stent
    Table 3. Major Manufacturers of Polymer Stent
    Table 4. Major Manufacturers of Others
    Table 5. Global Paclitaxel-eluting Stent Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Paclitaxel-eluting Stent Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Paclitaxel-eluting Stent Sales by Region (2017-2022) & (K Units)
    Table 8. Global Paclitaxel-eluting Stent Sales Market Share by Region (2017-2022)
    Table 9. Global Paclitaxel-eluting Stent Sales by Region (2023-2028) & (K Units)
    Table 10. Global Paclitaxel-eluting Stent Sales Market Share by Region (2023-2028)
    Table 11. Global Paclitaxel-eluting Stent Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Paclitaxel-eluting Stent Revenue Market Share by Region (2017-2022)
    Table 13. Global Paclitaxel-eluting Stent Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Paclitaxel-eluting Stent Revenue Market Share by Region (2023-2028)
    Table 15. Global Paclitaxel-eluting Stent Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Paclitaxel-eluting Stent Sales Share by Manufacturers (2017-2022)
    Table 17. Global Paclitaxel-eluting Stent Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Paclitaxel-eluting Stent Revenue Share by Manufacturers (2017-2022)
    Table 19. Paclitaxel-eluting Stent Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Paclitaxel-eluting Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Paclitaxel-eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel-eluting Stent as of 2021)
    Table 22. Paclitaxel-eluting Stent Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Paclitaxel-eluting Stent Product Offered
    Table 24. Date of Manufacturers Enter into Paclitaxel-eluting Stent Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Paclitaxel-eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 27. Global Paclitaxel-eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 28. Global Paclitaxel-eluting Stent Sales Share by Type (2017-2022)
    Table 29. Global Paclitaxel-eluting Stent Sales Share by Type (2023-2028)
    Table 30. Global Paclitaxel-eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Paclitaxel-eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Paclitaxel-eluting Stent Revenue Share by Type (2017-2022)
    Table 33. Global Paclitaxel-eluting Stent Revenue Share by Type (2023-2028)
    Table 34. Paclitaxel-eluting Stent Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Paclitaxel-eluting Stent Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Paclitaxel-eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 37. Global Paclitaxel-eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 38. Global Paclitaxel-eluting Stent Sales Share by Application (2017-2022)
    Table 39. Global Paclitaxel-eluting Stent Sales Share by Application (2023-2028)
    Table 40. Global Paclitaxel-eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Paclitaxel-eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Paclitaxel-eluting Stent Revenue Share by Application (2017-2022)
    Table 43. Global Paclitaxel-eluting Stent Revenue Share by Application (2023-2028)
    Table 44. Paclitaxel-eluting Stent Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Paclitaxel-eluting Stent Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Paclitaxel-eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 47. North America Paclitaxel-eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 48. North America Paclitaxel-eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Paclitaxel-eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Paclitaxel-eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 51. North America Paclitaxel-eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 52. North America Paclitaxel-eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Paclitaxel-eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Paclitaxel-eluting Stent Sales by Country (2017-2022) & (K Units)
    Table 55. North America Paclitaxel-eluting Stent Sales by Country (2023-2028) & (K Units)
    Table 56. North America Paclitaxel-eluting Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Paclitaxel-eluting Stent Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Paclitaxel-eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Paclitaxel-eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Paclitaxel-eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Paclitaxel-eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Paclitaxel-eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Paclitaxel-eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Paclitaxel-eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Paclitaxel-eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Paclitaxel-eluting Stent Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Paclitaxel-eluting Stent Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Paclitaxel-eluting Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Paclitaxel-eluting Stent Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Paclitaxel-eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Paclitaxel-eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Paclitaxel-eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Paclitaxel-eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Paclitaxel-eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Paclitaxel-eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Paclitaxel-eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Paclitaxel-eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Paclitaxel-eluting Stent Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Paclitaxel-eluting Stent Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Paclitaxel-eluting Stent Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Paclitaxel-eluting Stent Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Paclitaxel-eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Paclitaxel-eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Paclitaxel-eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Paclitaxel-eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Paclitaxel-eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Paclitaxel-eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Paclitaxel-eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Paclitaxel-eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Paclitaxel-eluting Stent Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Paclitaxel-eluting Stent Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Paclitaxel-eluting Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Paclitaxel-eluting Stent Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Paclitaxel-eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Paclitaxel-eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Paclitaxel-eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Paclitaxel-eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Paclitaxel-eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Paclitaxel-eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Paclitaxel-eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Paclitaxel-eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Paclitaxel-eluting Stent Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Paclitaxel-eluting Stent Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Paclitaxel-eluting Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Paclitaxel-eluting Stent Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Blue Medical Corporation Information
    Table 107. Blue Medical Description and Major Businesses
    Table 108. Blue Medical Paclitaxel-eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Blue Medical Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Blue Medical Recent Developments
    Table 111. Boston Scientific Corporation Information
    Table 112. Boston Scientific Description and Major Businesses
    Table 113. Boston Scientific Paclitaxel-eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Boston Scientific Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Boston Scientific Recent Developments
    Table 116. DISA Vascular Corporation Information
    Table 117. DISA Vascular Description and Major Businesses
    Table 118. DISA Vascular Paclitaxel-eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. DISA Vascular Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. DISA Vascular Recent Developments
    Table 121. Essen Corporation Information
    Table 122. Essen Description and Major Businesses
    Table 123. Essen Paclitaxel-eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Essen Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Essen Recent Developments
    Table 126. Medtronic Vascular Corporation Information
    Table 127. Medtronic Vascular Description and Major Businesses
    Table 128. Medtronic Vascular Paclitaxel-eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Medtronic Vascular Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Medtronic Vascular Recent Developments
    Table 131. MicroPort Medical Corporation Information
    Table 132. MicroPort Medical Description and Major Businesses
    Table 133. MicroPort Medical Paclitaxel-eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. MicroPort Medical Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. MicroPort Medical Recent Developments
    Table 136. Terumo Medical Corporation Information
    Table 137. Terumo Medical Description and Major Businesses
    Table 138. Terumo Medical Paclitaxel-eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Terumo Medical Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Terumo Medical Recent Developments
    Table 141. Orbusneich Corporation Information
    Table 142. Orbusneich Description and Major Businesses
    Table 143. Orbusneich Paclitaxel-eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Orbusneich Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Orbusneich Recent Developments
    Table 146. Cook Medical Corporation Information
    Table 147. Cook Medical Description and Major Businesses
    Table 148. Cook Medical Paclitaxel-eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Cook Medical Paclitaxel-eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Cook Medical Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Paclitaxel-eluting Stent Distributors List
    Table 154. Paclitaxel-eluting Stent Customers List
    Table 155. Paclitaxel-eluting Stent Market Trends
    Table 156. Paclitaxel-eluting Stent Market Drivers
    Table 157. Paclitaxel-eluting Stent Market Challenges
    Table 158. Paclitaxel-eluting Stent Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Paclitaxel-eluting Stent Product Picture
    Figure 3. Global Paclitaxel-eluting Stent Market Share by Type in 2021 & 2028
    Figure 3. Metal Stent Product Picture
    Figure 4. Polymer Stent Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Paclitaxel-eluting Stent Market Share by Application in 2021 & 2028
    Figure 7. Coronary Heart Disease
    Figure 8. Clinical
    Figure 9. Others
    Figure 10. Paclitaxel-eluting Stent Report Years Considered
    Figure 11. Global Paclitaxel-eluting Stent Sales 2017-2028 (K Units)
    Figure 12. Global Paclitaxel-eluting Stent Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Paclitaxel-eluting Stent Revenue 2017-2028 (US$ Million)
    Figure 14. Global Paclitaxel-eluting Stent Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Paclitaxel-eluting Stent Sales Market Share by Region (2017-2022)
    Figure 16. Global Paclitaxel-eluting Stent Sales Market Share by Region (2023-2028)
    Figure 17. North America Paclitaxel-eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Paclitaxel-eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Paclitaxel-eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Paclitaxel-eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Paclitaxel-eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Paclitaxel-eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Paclitaxel-eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Paclitaxel-eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Paclitaxel-eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Paclitaxel-eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Paclitaxel-eluting Stent Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Paclitaxel-eluting Stent in the World: Market Share by Paclitaxel-eluting Stent Revenue in 2021
    Figure 29. Global Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Paclitaxel-eluting Stent Sales Market Share by Type (2017-2028)
    Figure 31. Global Paclitaxel-eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 32. Global Paclitaxel-eluting Stent Sales Market Share by Application (2017-2028)
    Figure 33. Global Paclitaxel-eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 34. North America Paclitaxel-eluting Stent Sales Market Share by Type (2017-2028)
    Figure 35. North America Paclitaxel-eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 36. North America Paclitaxel-eluting Stent Sales Market Share by Application (2017-2028)
    Figure 37. North America Paclitaxel-eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 38. North America Paclitaxel-eluting Stent Sales Share by Country (2017-2028)
    Figure 39. North America Paclitaxel-eluting Stent Revenue Share by Country (2017-2028)
    Figure 40. U.S. Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Paclitaxel-eluting Stent Sales Market Share by Type (2017-2028)
    Figure 43. Europe Paclitaxel-eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Paclitaxel-eluting Stent Sales Market Share by Application (2017-2028)
    Figure 45. Europe Paclitaxel-eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Paclitaxel-eluting Stent Sales Share by Country (2017-2028)
    Figure 47. Europe Paclitaxel-eluting Stent Revenue Share by Country (2017-2028)
    Figure 48. Germany Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 49. France Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Paclitaxel-eluting Stent Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Paclitaxel-eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Paclitaxel-eluting Stent Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Paclitaxel-eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Paclitaxel-eluting Stent Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Paclitaxel-eluting Stent Revenue Share by Region (2017-2028)
    Figure 59. China Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 62. India Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Paclitaxel-eluting Stent Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Paclitaxel-eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Paclitaxel-eluting Stent Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Paclitaxel-eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Paclitaxel-eluting Stent Sales Share by Country (2017-2028)
    Figure 74. Latin America Paclitaxel-eluting Stent Revenue Share by Country (2017-2028)
    Figure 75. Mexico Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Paclitaxel-eluting Stent Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Paclitaxel-eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Paclitaxel-eluting Stent Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Paclitaxel-eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Paclitaxel-eluting Stent Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Paclitaxel-eluting Stent Revenue Share by Country (2017-2028)
    Figure 84. Turkey Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Paclitaxel-eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 87. Paclitaxel-eluting Stent Value Chain
    Figure 88. Paclitaxel-eluting Stent Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
Terumo Medical
Orbusneich
Cook Medical
Frequently Asked Questions
Paclitaxel-eluting Stent report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Paclitaxel-eluting Stent report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Paclitaxel-eluting Stent report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Paclobutrazol

Paclobutrazol market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Painting Robots

Painting Robots market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Pancreatic Stents

Pancreatic Stents market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More